Downloads
-
Streamline Experiments From Design To Decide
6/3/2026
Gain insight into how a connected approach to experimental design and data management helps reduce errors, accelerate iteration cycles, and unlock deeper insights.
-
Assess The Safety Of Pharmaceutical Impurities In Silico
6/3/2026
Advance impurity risk assessment with predictive modeling that clarifies toxicity mechanisms, strengthens regulatory arguments, and reduces experimental burden—helping teams make confident decisions.
-
Manage And Share Analytical Data With Context
6/3/2026
Disconnected analytical data slows discovery and limits insight. Take a look at how a unified, searchable environment brings structure, context, and automation to complex datasets.
-
Automate Method Development And Achieve QbD
6/3/2026
Learn about a smarter, data-driven path to chromatographic method development that reduces experimentation, predicts optimal conditions, and improves robustness—all while shortening timelines.
-
Develop Chromatographic Methods In Less Time
6/3/2026
ACD/AutoChrom helps experts develop chromatographic separations using QbD principles. It uses a workflow-based structure to streamline and track a project so you can:
- Begin with reasonable starting conditions and columns
- Define a strategy and implement it with help from software wizards and assistants
- Automatically run experiments for screening and optimization
- Model your separation in 1D, 2D, or 3D
- Document the reasons for your decisions and database your projects for future learning
-
Calculate Abraham Solvation Parameters
6/3/2026
Calculate Abraham Solvation Parameters and various solvation-related properties of solutes, directly from structure.
Use ACD/Absolv to:
- Predict solvation parameters A, B, BO, E, S, L, and V
- Calculate various solvent-solvent or gas-solvent partition coefficients
- Visualize the contributions of each atom in the structure to each Abraham solvation parameter
- Assess the relevance of the result
- Access a database of Abraham coefficients for >5000 compounds
-
FDA's New Oncology Guidance Signals The Next Phase Of Drug Development Reform
6/2/2026
New FDA guidance encourages streamlined nonclinical safety assessments for certain cancer therapies and explicitly seeks to reduce unnecessary animal testing while maintaining patient safety.
-
DDW 2026 Signalled The Next Era Of Competitive Landscape In IBD
6/2/2026
At the DDW 2026 meeting, the IBD landscape was portrayed as increasingly competitive and diversified, with emerging players and novel mechanisms challenging established standards of care.
-
Why Tolerability Will Drive The Next Wave Of Obesity Treatments
5/29/2026
For the next generation of obesity medicines, enhancing how patients experience therapy will inform discovery and development efforts and may ultimately determine long-term success.
-
Assay Development And Screening
5/28/2026
We deliver custom assay development, screening, potency, and selectivity testing services for the pharmaceutical, biopharmaceutical, and agrochemical industries.